Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2022 ∙ Aguiar de Sousa, D. Romoli, M. Sanchez Van Kammen, M. Heldner, M. R. Zini, A. Coutinho, J. M. Arnold, M. Ferro, J. M.

Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Fujio, K. Sung, J. Nakatani, S. Yamamoto, K. Iwagami, M. Fujimoto, K. Shokirova, H. Okumura, Y. Akasaki, Y. Nagino, K. Midorikawa-Inomata, A. Hirosawa, K. Miura, M. Huang, T. Morooka, Y. Kuwahara, M. Murakami, A. Inomata, T.

Characteristics and Clinical Ocular Manifestations in Patients with Acute Corneal Graft Rejection after Receiving the COVID-19 Vaccine: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Gopinath, S. Ishak, A. Dhawan, N. Poudel, S. Shrestha, P. S. Singh, P. Xie, E. Tahir, P. Marzaban, S. Michel, J. Michel, G.

Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Notarte, K. I. Guerrero-Arguero, I. Velasco, J. V. Ver, A. T. de Oliveira, M. H. S. Catahay, J. A. Khan, S. R. Pastrana, A. Juszczyk, G. Torrelles, J. B. Lippi, G. Martinez-Sobrido, L. Henry, B. M.

Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ma, Y. Ren, J. Zheng, Y. Cai, D. Li, S. Li, Y.

Chinese parents' willingness to vaccinate their children against COVID-19: A systematic review and meta-analysis

  • Western Pacific
  • China
  • Parents/caregivers
  • Children
  • Adolescents
  • Adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Fisher, S. Dodiuk-Gad, R. P. Ziv, M.

Chronic dermatoses exacerbation after COVID-19 vaccination - a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Matar, R. H. Mansour, R. Nakanishi, H. Smayra, K. El Haddad, J. Vankayalapati, D. K. Daniel, R. S. Tosovic, D. Than, C. A. Yamani, M. H.

Clinical Characteristics of Patients with Myocarditis following COVID-19 mRNA Vaccination: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ostovan, V. R. Sahraian, M. A. Karazhian, N. Rostamihosseinkhani, M. Salimi, M. Marbooti, H.

Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lee, C. J. Woo, W. Kim, A. Y. Yon, D. K. Lee, S. W. Koyanagi, A. Kim, M. S. Kalthoum, T. Dragioti, E. Radua, J. Lee, S. Smith, L. Il Shin, J.

Clinical Manifestations of COVID-19 Breakthrough Infections: A Systematic Review and Meta-Analysis

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Al-Qudimat, A. R. Al-Zoubi, R. M. Elaarag, M. Nashwan, A. J. Hamze, A. K. Bawadi, H. Yassin, A. Assim, A. Aboumarzouk, O. M. Zarour, A. Al-Ansari, A. A.

Clinical outcomes of Pfizer-BioNTech COVID-19 vaccine in children and adolescents: A systematic review

  • Children
  • Adolescents
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...